$TELA News

Earnings Release: Here's Why Analysts Cut Their TELA Bio, Inc. (NASDAQ:TELA) Price Target To US$2.25

TELA Bio, Inc. Q1 2026 Earnings Call Summary

TELA Bio Inc (TELA) Q1 2026 Earnings Call Highlights: Strong European Growth and Strategic U.S. ...

TELA Bio, Inc. (TELA) Reports Q1 Loss, Beats Revenue Estimates

TELA Bio, Inc. (TELA) Q1 2026 Earnings Call Transcript

TELA Bio (NASDAQ:TELA) Reports Mixed Q1 Results with Revenue Beat but Wider Loss and Cautious Q2 Guidance

TELA Bio Reports First Quarter 2026 Financial Results

TELA Bio Q1 2026 Earnings Call Transcript

TELA Bio FY2026 Revenue expected to be more than $86.697M vs $86.849M Est

TELA Bio Sees Q2 Sales $20.000M vs $21.043M Est

TELA Bio Q1 EPS $(0.21) Misses $(0.18) Estimate, Sales $19.059M Beat $18.597M Estimate

AbCellera Biologics Inc. (ABCL) Reports Q1 Loss, Beats Revenue Estimates

BridgeBio Pharma (BBIO) Reports Q1 Loss, Tops Revenue Estimates

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues

TELA Bio to Announce First Quarter 2026 Financial Results

Citizens Maintains Market Outperform on TELA Bio, Lowers Price Target to $3

TELA Bio Analysts Cut Their Forecasts After Q4 Results

Piper Sandler Maintains Neutral on TELA Bio, Lowers Price Target to $1

TELA Bio, Inc. Q4 2025 Earnings Call Summary